A-share biopharmaceutical stocks surged, with Sinovita rising over 10%, followed by gains in Shanghai RAAS, Sanyuan Gene, Boya Bio-Pharmaceutical, Pailin Bio-Pharmaceutical, and Maiwei Bio-Pharmaceutical.

2026-10-19

A-share biopharmaceutical stocks surged, with Sinovita rising over 10%, followed by gains in Shanghai RAAS, Sanyuan Gene, Boya Bio-Pharmaceutical, Pailin Bio-Pharmaceutical, and Maiwei Bio-Pharmaceutical.